ArticleClinical and translational science2021

Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment.

Benjamin Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.